Skip to main content
Erschienen in: Clinical Rheumatology 12/2014

01.12.2014 | Original Article

Agreement between FRAX scores calculated with and without bone mineral density in women with osteopenia in Turkey

verfasst von: Nese Olmez Sarikaya, Secil Kapar Yavasi, Gulten Tan, Servet Satiroglu, Arife Hilal Yildiz, Bengi Oz, Ozlem Yoleri, Asuman Memis

Erschienen in: Clinical Rheumatology | Ausgabe 12/2014

Einloggen, um Zugang zu erhalten

Abstract

This study aimed to analyze the agreement between FRAX scores calculated with and without femoral neck (FN) bone mineral density (BMD) and to investigate the resultant treatment recommendations in women with osteopenia. A cross-sectional review of postmenopausal women who were referred for DXA evaluation was conducted. One hundred twenty-nine postmenopausal women aged 40 years and older with osteopenia [FN T-score between −1 and (−2.5)] were recruited for the study. Absolute agreement between FRAX scores calculated with and without BMD was analyzed by intraclass correlation analysis (ICC). Thresholds recommended by National Osteoporosis Foundation were used for treatment recommendations. Correlation between demographic factors and the difference in BMD+ and BMD− FRAX scores was analyzed by Spearman correlation test. Agreement levels and treatment recommendations were also analyzed in 112/129 patients without previous fracture. Agreement between BMD+ and BMD− MO and hip FRAX scores was good (ICC 0.867) and fair to good (ICC 0.641), respectively. In patients without previous fracture, agreement between MO and hip fracture probabilities was good (ICC = 0.838 and ICC = 0.778, respectively). Treatment recommendations with respect to treatment threshold of ≥3 for hip fracture probabilities were identical in 120/129 (93 %) cases. Difference between BMD+ and BMD− fracture probabilities was correlated with age and FN BMD. In most cases, FRAX without BMD provided the same treatment recommendations as FRAX with BMD in postmenopausal women with osteopenia. Exclusion of patients with previous fracture yielded better agreement levels.
Literatur
1.
Zurück zum Zitat Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19(4):385–397PubMedCentralPubMedCrossRef Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19(4):385–397PubMedCentralPubMedCrossRef
2.
Zurück zum Zitat Kanis JA, McCloskey E, Johansson H, Oden A, Leslie WD (2012) FRAX (®) with and without bone mineral density. Calcif Tissue Int 90(1):1–13PubMedCrossRef Kanis JA, McCloskey E, Johansson H, Oden A, Leslie WD (2012) FRAX (®) with and without bone mineral density. Calcif Tissue Int 90(1):1–13PubMedCrossRef
3.
Zurück zum Zitat Johansson H, Kanis JA, Oden A, Johnell O, McCloskey E (2009) BMD, clinical risk factors and their combination for hip fracture prevention. Osteoporos Int 20:1675–1682PubMedCrossRef Johansson H, Kanis JA, Oden A, Johnell O, McCloskey E (2009) BMD, clinical risk factors and their combination for hip fracture prevention. Osteoporos Int 20:1675–1682PubMedCrossRef
4.
Zurück zum Zitat Leslie WD, Morin S, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA, for the Manitoba Bone Density Program (2012) Fracture risk assessment without bone density measurement in routine clinical practice. Osteoporos Int 23(1):75–85PubMedCrossRef Leslie WD, Morin S, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA, for the Manitoba Bone Density Program (2012) Fracture risk assessment without bone density measurement in routine clinical practice. Osteoporos Int 23(1):75–85PubMedCrossRef
5.
Zurück zum Zitat Leslie WD, Majumdar SR, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA, Manitoba Bone Density Program (2012) High fracture probability with FRAX usually indicates densitometric osteoporosis: implications for clinical practice. Osteoporos Int 23(1):391–397PubMedCrossRef Leslie WD, Majumdar SR, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA, Manitoba Bone Density Program (2012) High fracture probability with FRAX usually indicates densitometric osteoporosis: implications for clinical practice. Osteoporos Int 23(1):391–397PubMedCrossRef
6.
Zurück zum Zitat National Osteoporosis Foundation (2010) Clinician’s guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation, Washington, DC National Osteoporosis Foundation (2010) Clinician’s guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation, Washington, DC
7.
Zurück zum Zitat Kanis JA, Hans D, Cooper C, Baim S, Bilezikian JP, Binkley N, Cauley JA, Compston JE, Dawson-Hughes B, El-Hajj Fuleihan G, Johansson H, Leslie WD, Lewiecki EM, Luckey M, Oden A, Papapoulos SE, Poiana C, Rizzoli R, Wahl DA, McCloskey EV (2011) Task force of the FRAX initiative. Interpretation and use of FRAX in clinical practice. Osteoporos Int 22(9):2395–2411PubMedCrossRef Kanis JA, Hans D, Cooper C, Baim S, Bilezikian JP, Binkley N, Cauley JA, Compston JE, Dawson-Hughes B, El-Hajj Fuleihan G, Johansson H, Leslie WD, Lewiecki EM, Luckey M, Oden A, Papapoulos SE, Poiana C, Rizzoli R, Wahl DA, McCloskey EV (2011) Task force of the FRAX initiative. Interpretation and use of FRAX in clinical practice. Osteoporos Int 22(9):2395–2411PubMedCrossRef
8.
Zurück zum Zitat Wainwright SA, Marshall LM, Ensrud KE, Cauley JA, Black DM, Hillier TA, Hochberg MC, Vogt MT, Orwoll ES; Study of Osteoporotic Fractures Research Group (2005) Hip fracture in women without osteoporosis. J Clin Endocrinol Metab 90(5):2787–2793CrossRef Wainwright SA, Marshall LM, Ensrud KE, Cauley JA, Black DM, Hillier TA, Hochberg MC, Vogt MT, Orwoll ES; Study of Osteoporotic Fractures Research Group (2005) Hip fracture in women without osteoporosis. J Clin Endocrinol Metab 90(5):2787–2793CrossRef
9.
Zurück zum Zitat Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B, Oden A, Zethraeus N, Pfleger B, Khaltaev N (2005) Assessment of fracture risk. Osteoporos Int 16(6):581–589PubMedCrossRef Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B, Oden A, Zethraeus N, Pfleger B, Khaltaev N (2005) Assessment of fracture risk. Osteoporos Int 16(6):581–589PubMedCrossRef
10.
Zurück zum Zitat Fleiss JL (1986) The design and analysis of clinical experiments. John Wiley & Sons Inc, New York, pp 1–32 Fleiss JL (1986) The design and analysis of clinical experiments. John Wiley & Sons Inc, New York, pp 1–32
11.
Zurück zum Zitat Tuzun S, Eskiyurt N, Akarirmak U, Saridogan M, Johansson H, McCloskey E, Kanis JA (2012) Turkish osteoporosis society. The impact of a FRAX-based intervention threshold in Turkey: the FRAX-TURK study. Arch Osteoporos 7(1–2):229–235PubMedCrossRef Tuzun S, Eskiyurt N, Akarirmak U, Saridogan M, Johansson H, McCloskey E, Kanis JA (2012) Turkish osteoporosis society. The impact of a FRAX-based intervention threshold in Turkey: the FRAX-TURK study. Arch Osteoporos 7(1–2):229–235PubMedCrossRef
12.
Zurück zum Zitat Ilias I, Spanoudi F, Koukkou E, Nikopoulou SC (2012) Use of the FRAX calculator with and without bone mineral density in Greek women. Hormones (Athens) 11(2):222–223CrossRef Ilias I, Spanoudi F, Koukkou E, Nikopoulou SC (2012) Use of the FRAX calculator with and without bone mineral density in Greek women. Hormones (Athens) 11(2):222–223CrossRef
13.
Zurück zum Zitat Hamdy RC, Kiebzak GM (2009) Variance in 10-year fracture risk calculated with and without T-scores in select subgroups of normal and osteoporotic patients. J Clin Densitom 12(2):158–161PubMedCrossRef Hamdy RC, Kiebzak GM (2009) Variance in 10-year fracture risk calculated with and without T-scores in select subgroups of normal and osteoporotic patients. J Clin Densitom 12(2):158–161PubMedCrossRef
14.
15.
Zurück zum Zitat Lewiecki EM, Bilezikian JP, Khosla S, Marcus R, McClung MR, Miller PD, Watts NB, Maricic M (2011) Osteoporosis update from the 2010 Santa Fe bone symposium. J Clin Densitom 14(1):1–21PubMedCrossRef Lewiecki EM, Bilezikian JP, Khosla S, Marcus R, McClung MR, Miller PD, Watts NB, Maricic M (2011) Osteoporosis update from the 2010 Santa Fe bone symposium. J Clin Densitom 14(1):1–21PubMedCrossRef
16.
Zurück zum Zitat Gómez-Vaquero C, Bianchi M, Santo P, Roig-Vilaseca D, Narváez J, Nolla JM (2012) The activity of a Spanish bone densitometry unit revisited under the point of view of FRAX. Reumatol Clin 8(4):179–183PubMedCrossRef Gómez-Vaquero C, Bianchi M, Santo P, Roig-Vilaseca D, Narváez J, Nolla JM (2012) The activity of a Spanish bone densitometry unit revisited under the point of view of FRAX. Reumatol Clin 8(4):179–183PubMedCrossRef
17.
Zurück zum Zitat Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A, Oglesby A (2002) International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res 17:1237–1244PubMedCrossRef Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A, Oglesby A (2002) International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res 17:1237–1244PubMedCrossRef
18.
Zurück zum Zitat Assessment of osteoporosis at the primary health care level (2007) Report of a WHO scientific group. World Health Organization Collaborating Center for Metabolic Bone Diseases. Sheffield UK: University of Sheffield Assessment of osteoporosis at the primary health care level (2007) Report of a WHO scientific group. World Health Organization Collaborating Center for Metabolic Bone Diseases. Sheffield UK: University of Sheffield
19.
Zurück zum Zitat Kanis JA (2008) on behalf of the World Health Organization Scientific Group Assessment of osteoporosis at the primary healthcare level. Technical Report. WHO Collaborating Centre, University of Sheffield, UK Kanis JA (2008) on behalf of the World Health Organization Scientific Group Assessment of osteoporosis at the primary healthcare level. Technical Report. WHO Collaborating Centre, University of Sheffield, UK
20.
Zurück zum Zitat Compston J, Bowring C, Cooper A, Cooper C, Davies C, Francis R, Kanis JA, Marsh D, McCloskey EV, Reid DM, Selby P (2013) Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update. Maturitas 75(4):392–396PubMedCrossRef Compston J, Bowring C, Cooper A, Cooper C, Davies C, Francis R, Kanis JA, Marsh D, McCloskey EV, Reid DM, Selby P (2013) Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update. Maturitas 75(4):392–396PubMedCrossRef
21.
Zurück zum Zitat Aubry-Rozier B, Stoll D, Krieg MA, Lamy O, Hans D (2013) What was your fracture risk evaluated by FRAX® the day before your osteoporotic fracture? Clin Rheumatol 32(2):219–223PubMedCrossRef Aubry-Rozier B, Stoll D, Krieg MA, Lamy O, Hans D (2013) What was your fracture risk evaluated by FRAX® the day before your osteoporotic fracture? Clin Rheumatol 32(2):219–223PubMedCrossRef
22.
Zurück zum Zitat Watts NB, Siris ES, Cummings SR, Bauer DC (2010) Filtering FRAX. Osteoporos Int 21(4):537–541PubMedCrossRef Watts NB, Siris ES, Cummings SR, Bauer DC (2010) Filtering FRAX. Osteoporos Int 21(4):537–541PubMedCrossRef
Metadaten
Titel
Agreement between FRAX scores calculated with and without bone mineral density in women with osteopenia in Turkey
verfasst von
Nese Olmez Sarikaya
Secil Kapar Yavasi
Gulten Tan
Servet Satiroglu
Arife Hilal Yildiz
Bengi Oz
Ozlem Yoleri
Asuman Memis
Publikationsdatum
01.12.2014
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 12/2014
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-014-2491-8

Weitere Artikel der Ausgabe 12/2014

Clinical Rheumatology 12/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.